PIGV
protein-codingphosphatidylinositol glycan anchor biosynthesis class V, the group of Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis
Gene summary
This gene encodes a mannosyltransferase enzyme involved in the biosynthesis of glycosylphosphatidylinositol (GPI). GPI is a complex glycolipid that functions as a membrane anchor for many proteins and plays a role in multiple cellular processes including protein sorting and signal transduction. The encoded protein is localized to the endoplasmic reticulum and transfers the second mannose to the GPI backbone. Mutations in this gene are associated with hyperphosphatasia cognitive disability syndrome. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Feb 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009398
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009398
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016596
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009398
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009398
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009398
Submitter: ClinGen
*PIGV* was first reported in relation to autosomal recessive hyperphosphatasia with intellectual disability syndrome 1 in 2010 (Krawitz et al., PMID: 20802478). 14 unique variants (13 missense, 1 nonsense) that have been reported in 18 probands in 8 publications (PMIDs: 20802478, 21739589, 22315194, 24129430, 27177984, 28688840, 28817240, 37863628) are included in this curation. One recurrent variant in the European population (NM_017837.4:c.1022C>A, p.Ala341Glu) has been observed in the homozygous state in 5 probands and in the compound heterozygous state in 9 probands. The mechanism of pathogenicity appears to be loss of function, although most variants reported in conjunction with this condition are missense variants without functional studies. This gene-disease relationship is also supported by a mouse knock-in model and a Chinese hamster ovary cell knockout model (PMIDs: 33402532, 22228761). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date June 18, 2025 (SOP Version 11).
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PIGV variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017837.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 127 | 130 | |||
| missense | 3 | 9 | 176 | 13 | 201 | |
| nonsense | 5 | 5 | 10 | |||
| start loss | 0 | |||||
| frameshift | 2 | 11 | 13 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 3 | 17 | 195 | 140 | 0 | 355 |
Highest pathogenic variant AF is 0.00012452883
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060307.2 | 3 | MANE Select | |
| Ensembl | ENSP00000501479.1 | 3 | MANE Select | |
| RefSeq | NP_001189483.1 | 3 | Standard | |
| RefSeq | NP_001361407.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
- Vitamin B6-dependent and responsive disorders
- Synthesis of glycosylphosphatidylinositol (GPI)
- Post-translational modification: synthesis of GPI-anchored proteins
- Post-translational protein modification
Biological Process
- GPI anchor biosynthetic process
- preassembly of GPI anchor in ER membrane
- mannosylation
Molecular Function
- mannosyltransferase activity
- glycolipid mannosyltransferase activity
- dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity
Cellular Component
- endoplasmic reticulum membrane
- integral component of membrane
- mannosyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374145
- Coding exons
- 3
- Length
- 10927
- Individuals with no LoFs
- 125690
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 58
- Defined
- 125748
- p
- 0.000231
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.398 | 240 | 258 | 0.930 | 0.0000139 | 3169 |
| Missense (PolyPhen) | 78 | 93.661 | 0.83279 | 1231 | ||
| Synonymous | 0.202 | 106 | 109 | 0.975 | 0.00000582 | 1074 |
| Loss of Function | 0.811 | 14 | 17.7 | 0.792 | 9.52e-7 | 190 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00034 | 0.00034 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Alpha-1,6-mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the second mannose to the glycosylphosphatidylinositol during GPI precursor assembly. {ECO:0000269|PubMed:15623507, ECO:0000269|PubMed:15720390}.;
- Disease
- DISEASE: Hyperphosphatasia with mental retardation syndrome 1 (HPMRS1) [MIM:239300]: A severe syndrome characterized by elevated serum alkaline phosphatase, severe mental retardation, seizures, hypotonia, facial dysmorphism, and hypoplastic terminal phalanges. {ECO:0000269|PubMed:20802478}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.258
- RVIS EVS
- -0.4
- RVIS percentile EVS
- 26.73
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.465
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |